Clinical Trials Browser

Phase 1 × Neoplasms × tosedostat × Clear all

NCT00737555 2012-02-15

A Study of the Safety and Tolerability of the Addition of CHR-2797 to Paclitaxel in Patients With Advanced or Refractory Tumours

Phase 1 Completed

Neoplasms